- Home
- NVRO vs TNYA Comparison
NVRO vs TNYA Comparison
Compare NVRO & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRO
- TNYA
- Stock Information
- Founded
- NVRO 2006
- TNYA 2016
- Country
- NVRO United States
- TNYA United States
- Employees
- NVRO N/A
- TNYA N/A
- Industry
- NVRO Medical/Dental Instruments
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- NVRO Health Care
- TNYA Health Care
- Exchange
- NVRO Nasdaq
- TNYA Nasdaq
- Market Cap
- NVRO 139.0M
- TNYA 119.2M
- IPO Year
- NVRO 2014
- TNYA 2021
- Fundamental
- Price
- NVRO $4.57
- TNYA $1.40
- Analyst Decision
- NVRO Hold
- TNYA Strong Buy
- Analyst Count
- NVRO 14
- TNYA 4
- Target Price
- NVRO $7.97
- TNYA $17.33
- AVG Volume (30 Days)
- NVRO 572.2K
- TNYA 3.8M
- Earning Date
- NVRO 02-19-2025
- TNYA 03-17-2025
- Dividend Yield
- NVRO N/A
- TNYA N/A
- EPS Growth
- NVRO N/A
- TNYA N/A
- EPS
- NVRO N/A
- TNYA N/A
- Revenue
- NVRO $419,146,000.00
- TNYA N/A
- Revenue This Year
- NVRO N/A
- TNYA N/A
- Revenue Next Year
- NVRO $0.64
- TNYA N/A
- P/E Ratio
- NVRO N/A
- TNYA N/A
- Revenue Growth
- NVRO N/A
- TNYA N/A
- 52 Week Low
- NVRO $3.17
- TNYA $0.99
- 52 Week High
- NVRO $19.47
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- NVRO 60.51
- TNYA 37.13
- Support Level
- NVRO $3.17
- TNYA $1.43
- Resistance Level
- NVRO $3.99
- TNYA $1.63
- Average True Range (ATR)
- NVRO 0.33
- TNYA 0.12
- MACD
- NVRO 0.13
- TNYA 0.03
- Stochastic Oscillator
- NVRO 93.98
- TNYA 24.59
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.